This is a StreetInsider.com Premium Only Page

Regeneron (REGN) – Major News

Aug 3, 2023 06:33 AM Regeneron (REGN) Tops Q2 EPS by 39c, beats revenue

May 4, 2023 06:33 AM Regeneron (REGN) Tops Q1 EPS by 53c

Feb 3, 2023 06:33 AM Regeneron (REGN) Tops Q4 EPS by $2.39, Revenues Beat

Nov 3, 2022 06:32 AM Regeneron (REGN) Tops Q3 EPS by 132c

Aug 3, 2022 06:38 AM Regeneron (REGN) Tops Q2 EPS by $1.17

May 4, 2022 06:32 AM Regeneron (REGN) Tops Q1 EPS by $1.45

Apr 19, 2022 07:00 AM Regeneron (REGN) Acquires Checkmate Pharmaceuticals (CMPI) for $10.50/sh Cash

Feb 4, 2022 06:31 AM Regeneron (REGN) Tops Q4 EPS by $5.35

Nov 4, 2021 06:37 AM Regeneron (REGN) Tops Q3 EPS by $6.15

Aug 5, 2021 06:33 AM Regeneron (REGN) Tops Q2 EPS by $8.11, Sales Pounce Consensus

May 6, 2021 06:35 AM Regeneron (REGN) Tops Q1 EPS by 89c, Revenues Miss

Feb 5, 2021 06:32 AM Regeneron (REGN) Tops Q4 EPS by $1.10

Nov 23, 2020 06:07 AM Regeneron's (REGN) COVID-19 Antibody Cocktail REGEN-COV2 Receive FDA Emergency Use Authorization

Nov 5, 2020 06:50 AM Regeneron (REGN) Tops Q3 EPS by $1.23, Revenues Beat

Aug 5, 2020 06:39 AM Regeneron (REGN) Tops Q2 EPS by $1.18, Revenues Beat

May 5, 2020 06:31 AM Regeneron (REGN) Tops Q1 EPS by 47c

Feb 6, 2020 06:32 AM Regeneron (REGN) Tops Q4 EPS by 58c

Nov 5, 2019 06:32 AM Regeneron (REGN) Tops Q3 EPS by 31c, Offers FY Guidance

Aug 6, 2019 06:43 AM Regeneron (REGN) Tops Q2 EPS by 61c, Revenues Beat

May 7, 2019 06:36 AM Regeneron (REGN) Misses Q1 EPS by 101c, Revenues Miss; Provides FY19 Operating Outlook

Apr 8, 2019 07:02 AM Alnylam (ALNY), Regeneron (REGN) Announce Pact on RNAi Therapeutics Focused on Ocular and CNS Diseases; Regeneron to Make Payment of $400M Upfront and Purchase Stock at $90/Share

Feb 6, 2019 06:32 AM Regeneron (REGN) Tops Q4 EPS by $1.06, Revenues Beat; Offers FY19 Financial Guidance

Nov 6, 2018 06:37 AM Regeneron (REGN) Tops Q3 EPS by 69c, Revenues Beat

Aug 2, 2018 06:38 AM Regeneron (REGN) Tops Q2 EPS by 75c

May 3, 2018 06:31 AM Regeneron (REGN) Tops Q1 EPS by 35c, Updates FY Guidance

Mar 12, 2018 05:41 AM Regeneron (REGN) and Sanofi (SNY) Announce Praluent Met Primary Endpoint of Reducing Cardiovascular Events

Feb 8, 2018 06:32 AM Regeneron (REGN) Tops Q4 EPS by 70c

Nov 8, 2017 06:36 AM Regeneron (REGN) Tops Q3 EPS by 14c, Beats on Revenues

Aug 3, 2017 06:35 AM Regeneron (REGN) Tops Q2 EPS by 104c, Sales Beat

May 4, 2017 06:40 AM Regeneron (REGN) Misses Q1 EPS by 15c, Offers FY Guidance

Mar 28, 2017 11:41 AM Regeneron (REGN) and Sanofi (SNY) Announce FDA Approval of DUPIXENT to Treat Moderate-to-Severe Atopic Dermatitis

Mar 28, 2017 11:38 AM Regeneron's (REGN) Dupixent Receives FDA Approval

Feb 9, 2017 06:31 AM Regeneron (REGN) Tops Q4 EPS by 1c

Feb 8, 2017 05:32 PM Regeneron (REGN) and Sanofi (SNY) Confirm Stay of Permanent Injunction for Praluent (AMGN)

Feb 8, 2017 04:20 PM Sanofi (SNY), Regeneron (REGN) Win Order Letting Praluent Sales Continue - Bloomberg

Jan 5, 2017 04:43 PM Amgen (AMGN) Wins Ban on Sanofi's (SNY) Sales of Praluent Cholesterol Drug - Bloomberg

Nov 4, 2016 06:31 AM Regeneron (REGN) Tops Q3 EPS by 40c; EYLEA Sales Rose 16%

Oct 28, 2016 02:36 PM Regeneron (REGN), Sanofi (SNY) Receive FDA Complete Response Letter for Sarilumab BLA as RA Treatment

Aug 4, 2016 06:32 AM Regeneron (REGN) Tops Q2 EPS by 17c; Updates FY16 Expectations

May 5, 2016 06:36 AM Regeneron (REGN) Misses Q1 EPS by 1c; Reaffirms

Feb 9, 2016 06:32 AM Regeneron (REGN) Misses Q4 EPS by 48c

Nov 4, 2015 06:31 AM Regeneron (REGN) Tops Q3 EPS by 33c

Aug 4, 2015 06:34 AM Regeneron (REGN) Tops Q2 EPS by 12c

Jul 24, 2015 02:21 PM FDA Approves Sanofi (SNY)/Regeneron's (REGN) Praluent to Treat Certain Patients with High Cholesterol

Jun 9, 2015 06:34 PM Regeneron (REGN) Confirms FDA Panel Backing of Praluent

May 7, 2015 06:34 AM Regeneron (REGN) Tops Q1 EPS by 20c; Boosts U.S. EYLEA Sales Outlook

Feb 10, 2015 06:32 AM Regeneron (REGN) Tops Q4 EPS by 1c

Nov 4, 2014 06:31 AM Regeneron (REGN) Misses Q3 EPS by 5c

Aug 5, 2014 06:34 AM Regeneron Pharma (REGN) Tops Q2 EPS by 17c; EYLEA Sales Rose 26%

Jul 30, 2014 06:31 AM Regeneron Pharma (REGN) EYLEA Approved for Diabetic Macular Edema